Uterine fibroid embolization (UFE) is a minimally invasive procedure that shrinks fibroids by cutting off their blood supply. Instead of surgically removing fibroids or the uterus itself, a specialist threads a thin tube through an artery and injects tiny particles that block blood flow to the fibroids, causing them to gradually shrink. It controls heavy menstrual bleeding in roughly 83% to 92% of patients and allows most people to return to normal activities within two weeks.
How the Procedure Works
Fibroids depend on a rich blood supply to grow. UFE exploits that dependency. A specialist called an interventional radiologist makes a small puncture near your groin to access the femoral artery, then guides a thin catheter through your blood vessels toward the uterine arteries. The path is mapped in real time using X-ray imaging and contrast dye, which lights up on the screen so the doctor can see exactly where blood flows to the uterus.
Once the catheter reaches the uterine arteries, tiny particles (typically made of gelatin or plastic) are injected through it. These particles lodge in the small vessels feeding the fibroids and block blood flow. Starved of oxygen and nutrients, the fibroid tissue gradually dies and shrinks over the following weeks and months. The surrounding healthy uterine tissue survives because it draws blood from other smaller vessels that aren’t blocked.
You’re sedated but awake during the procedure, which typically takes one to two hours. It does not require general anesthesia or a surgical incision beyond the small puncture site.
Who Is a Good Candidate
The best candidates for UFE are premenopausal women with heavy regular menstrual bleeding or significant pain caused by intramural fibroids (the type that grows within the uterine wall) who do not plan to become pregnant in the future. If your primary symptoms are heavy periods, pelvic pressure, or pain during menstruation, UFE directly targets the source of those problems.
Several situations make UFE a poor fit or rule it out entirely. These include active pregnancy, active uterine infection, known or suspected uterine cancer, and fibroids that are very small (under 1 cm), already dead on imaging, or attached to the uterus by a thin stalk (pedunculated fibroids). Extremely large fibroids, where the uterus has grown to the size you’d expect at 24 weeks of pregnancy, also call for extra caution. Severe kidney problems, uncontrollable bleeding disorders, and serious contrast dye allergies are additional barriers.
Two groups fall into a gray area: people who want to get pregnant later and people whose symptoms stem from adenomyosis rather than fibroids. Professional guidelines from the Society of Interventional Radiology classify these as topics worth discussing with your doctor rather than outright disqualifications. If future pregnancy matters to you, that conversation is especially important because UFE’s effects on fertility are not fully settled.
What Recovery Looks Like
The first 24 hours after UFE are the most uncomfortable. Pain and cramping typically build during the first two to three hours, hold steady for about 8 to 12 hours, then gradually decrease. Most people also experience low-grade fever, nausea, fatigue, and loss of appetite in the first few days. This cluster of symptoms, called post-embolization syndrome, affects the majority of patients and is a normal response to the fibroid tissue breaking down.
Pain management starts before the procedure and continues through recovery. You’ll receive anti-inflammatory medications and, if needed, stronger pain relief during the initial peak. By the time you go home (usually the same day or the next morning), the worst of the cramping has passed, though a lower level of discomfort can linger for several days.
Plan to take it easy. Avoid lifting more than 10 pounds for the first 48 hours and skip strenuous exercise for at least a week, including activities that increase blood flow to the abdomen like certain yoga positions. Most people need about two weeks off work for a full recovery. Beyond that point, you can generally resume all normal activities.
How Effective UFE Is
Large studies consistently show that UFE controls heavy menstrual bleeding in 83% to 92% of patients, with results holding at the one-year mark. Menstrual pain improves in about 77% to 79% of cases, and bulk-related symptoms like urinary frequency (caused by a fibroid pressing on the bladder) improve in roughly 86%. These numbers come from studies tracking hundreds to thousands of patients across multiple centers.
Long-term durability is good but not perfect. At a median follow-up of five years, about 10% of patients need a second procedure, whether that’s a repeat embolization, a myomectomy, or a hysterectomy. That means the vast majority of patients get lasting relief from a single treatment, but there is a meaningful chance fibroids can regrow or new ones can develop over time.
Risks and Complications
UFE carries a lower complication rate than surgical alternatives. The infection rate is roughly 1 in 200, far lower than for hysterectomy, and serious life-threatening complications are extremely rare. Up to 16% of patients experience a temporary vaginal discharge in the months following the procedure, and about 10% will pass fibroid fragments, which can be startling but is part of the body expelling the dead tissue.
The most important long-term risk to understand is the effect on ovarian function. In women younger than 45, the chance of entering early menopause after UFE is low, ranging from 0% to 3%. For women older than 45, that risk jumps to 20% to 40%. This happens because the particles can sometimes travel to the ovarian arteries and reduce blood flow to the ovaries. If you’re in your mid-40s or older and considering UFE, this is a factor worth weighing carefully.
How UFE Compares to Myomectomy
Myomectomy surgically removes fibroids while preserving the uterus. It’s the main alternative for people who want to keep their uterus and possibly become pregnant. The two procedures have distinct tradeoffs.
UFE tends to involve a shorter hospital stay and a faster initial recovery. It also carries a lower rate of major complications: one large study found a 2.9% major complication rate for UFE compared to 8% for myomectomy, where complications included blood clots, internal bleeding, bowel obstruction, and sepsis. On the other hand, UFE is associated with roughly double the rate of needing a follow-up procedure compared to myomectomy. In pooled data from seven studies, patients who had UFE were about 2.2 times more likely to need reintervention than those who had myomectomy.
In practical terms, UFE offers a less invasive option with a quicker recovery and fewer surgical risks, but myomectomy may provide a more durable result and is generally preferred when future pregnancy is the goal. Neither option is universally better. The right choice depends on your fibroid size and location, your symptoms, whether you want children, and how you weigh a shorter recovery against a potentially higher chance of needing treatment again down the road.